Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

12.68
Delayed Data
As of Sep 30
 +0.41 / +3.34%
Today’s Change
5.25
Today|||52-Week Range
72.80
+2.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization166.0K159.0K46.0K96.0K
 
 
 
 
 
 
Operating ExpensesGross Income-166.0K-159.0K-46.0K-96.0K
 
 
 
 
 
General Expenses17.2M10.2M6.4M3.4M
 
 
 
 
 
Research And Development14.4M7.2M3.4M-103.0K
 
 
 
 
 
Total Operating Expenses17.4M10.4M6.4M3.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.4M-10.4M-6.4M-3.5M
 
 
 
 
 
Interest Expense On Debt234.0K156.0K77.0K0.00
 
 
 
 
Other Expenses0.000.000.0091.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-17.6M-10.5M-6.5M-3.4M
 
 
 
 
 
Net Income-17.6M-10.5M-6.5M-3.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.9M3.9M3.9M3.9M
 
 
 
 
 
Shares To Calculate EPS Diluted3.9M3.9M3.9M3.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$4.55-$2.80-$1.75-$0.70
 
 
 
 
 
EPS Diluted-$4.55-$2.80-$1.75-$0.70